Global Industry News

Latest Trends and Developments Across All the Industries

Global Assisted Reproductive Technology Market To Record Significant Rise In Revenue Share During Forecast Period : Fact.MR

In-vitro fertilization (IVF) technology would account for an unrivalled patient base, as compared to surrogacy and artificial insemination, on the back of the high success rate of the procedure. The introduction of preimplantation genetic diagnosis (PGD) technology helps medical professionals screen embryos for inherited diseases, which further improves the prospects of conceiving a healthy child.

Conditions such as PCOD/PCOS are found to worsen the reproductive performance of women, which leads to remote chances of conceivability, thereby encouraging women to undergo infertility treatment using assisted reproductive technology. Based on these relevant insights, authors of an exclusive Fact.MR study estimate a CAGR of around 6.3% for the expansion of the assisted reproductive technology market during the forecast period (2020-2025).

For detailed insights on enhancing your product footprint, request for a sample here –

Key Highlights of Assisted Reproductive Technology Market Study

  • High costs associated with quality IVF and IUI procedures are gradually propelling a shift of patients from assisted reproductive technology towards naturopathic solutions and alternative therapies to treat infertility, which is posing as a threat to developmental efforts of market players.
  • Increasing number of dual working households with a career-intensive approach, in turn, continues to increase reproductive complexity, which is taken into account by major corporates. Efforts have been made by major companies, such as Google LLC, towards creating a conducive environment for female employees by offering facilities to store their eggs, thereby stimulating growth of the assisted reproductive technology market.
  • Initiatives taken by numerous public and private institutions such as ASPIRE are projected to raise awareness and increase the adoption of assisted reproductive technology in Asia Pacific. Public awareness campaigns are also being witnessed in the U.S. by central authorities such as the Society for Assisted Reproductive Technology and National Infertility Association, which is reflecting on the growing patient base for infertility treatment.
  • Cost benefits of artificial reproductive techniques in developing countries of Asia Pacific are attracting reproductive care seekers from across the world. The study finds that, a complete package of surrogacy costs merely one-third of that in the U.K., which is strengthening the position of Asia Pacific as a key surrogacy destination.

Cross-border Reproductive Care Turning into a Phenomena in Assisted Reproductive Technology Market

The study finds that, variations in reimbursement facilities, cost, and patient outcomes in various countries lead to differences in the use of assisted reproductive technology. As per a study published by Springer, 53% of individuals in the Netherlands opt to go abroad to receive quality treatment. Additionally, around 57% to 80% individuals consider legal restriction as one of the chief causes, owing to which, they seek cross-border reproductive care in European countries such as Denmark, Spain, and Switzerland. High-quality fertility treatment services in tandem with the use of advanced technology is creating a favourable growth environment for the European assisted reproductive technology market.

For critical insights on this market, request for methodology here –

Assisted Reproductive Technology Market – Assessment of Key Segments

Authors of this comprehensive study have classified the assisted reproductive technology market into key segments for an in-depth study of the market. Categorisation of the assisted reproductive technology market is based on procedure, technology, end user, and region.

This detailed study also offers information about the incremental opportunity present in the assistive reproductive technology market during the forecast period. Key segments considered while studying the assisted reproductive technology market include:

  • Frozen Donor
  • Frozen Non-donor
  • Fresh Donor
  • Fresh Non-donor
  • Embryo Banking
  • In-vitro Fertilization
    • Intra-cytoplasmic Sperm Injection (ICSI)
    • Preimplantation Genetic Diagnosis (PGD)
  • Surrogacy
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
    • Others
  • Others
End User
  • Fertility Clinics
  • Hospitals
  • Others
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Authors of the report have taken ample care to track the latest movement of the assisted reproductive technology market, to ensure that only accurate information reaches stakeholders. The study helps these stakeholders in gaining an edge over their competitors. This exclusive guide also tracks the current as well as future trends that are likely to influence the growth of the assisted reproductive technology market during the forecast period.

A subject matter expert at Fact.MR opines, “Currently, Europe, North America, Latin America, and a handful of countries in Asia Pacific and the Middle East & Africa have regulations protecting the legal rights of the homosexual populace. However, homosexually-close relationships are progressively gaining acceptance in other countries too, which is indicative of the high demand for assisted reproductive technology in future.”

For in-depth competitive analysis, buy now –

Cost-effectiveness of Alternative Medicines to Remain Pertinent Threat for Players

Numerous threats and challenges with varying influence are encountered by players in the assisted reproductive technology market, including threats of cost-effective alternative therapies and choice of child adoption. Though entry barriers in the assisted reproductive technology are high, on the back of huge CAPEX and OPEX requirements, intense development activities undertaken by existing players are influential enough to turn the landscape fragmented.

For instance, a key player—Nidacon International AB—focuses on product innovation in the sperm diagnostic segment, and, in turn, extends efforts towards upgrading its existing product lines. Collaborations and alliances among leading players are also projected to foster improvements in fertility techniques, thereby leading to advancements in assisted reproductive technology.

Leave a Reply

Your email address will not be published. Required fields are marked *